Fintel reports that on February 6, 2025, Wedbush initiated coverage of Bicara Therapeutics (NasdaqGM:BCAX) with a Outperform ...

In a report released today, Jay McCanless from Wedbush maintained a Hold rating on LGI Homes (LGIH – Research Report), with a price target of ...

In a report released today, Robert Driscoll from Wedbush maintained a Buy rating on Kura Oncology (KURA – Research Report), with a price target ...

Tesla, Inc. (NASDAQ:TSLA – Get Free Report) fell 3.3% on Thursday after an insider sold shares in the company. The company ...

Dan Ives, Wedbush Securities managing director and global head of tech research, reacts to Amazon's first-quarter forecast. He speaks on "Bloomberg The Close." Amazon projected operating income of $14 ...

Palantir trades at valuations such that the stock still looks richly valued even after hyperbolic growth in its business.

While the sector leaders grapple with the DeepSeek fallout, smaller AI companies see an opportunity to scale with the Chinese ...

Since Palantir reported results, Yahoo Finance data shows there have been several upward revisions to EPS expectations for ...

In many ways, these have been tough days for Tesla. Falling sales. Squeezed profit margins. Proposed changes in US government ...

Adicet Bio (NASDAQ:ACET – Get Free Report)‘s stock had its “neutral” rating reissued by investment analysts at HC Wainwright in a research note issued on Wednesday,Benzinga reports. A number of other ...

Take-Two Interactive Software forecast its fourth-quarter bookings below estimates on Thursday, owing to weaker spending on ...